301 related articles for article (PubMed ID: 8199576)
1. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
3. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
Roychowdhury DF; Linker CA
Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
[TBL] [Abstract][Full Text] [Related]
5. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
[TBL] [Abstract][Full Text] [Related]
6. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
7. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
8. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.
Selleri C; Raiola A; De Rosa G; Luciano L; Pezzullo L; Picardi M; Rotoli B
Bone Marrow Transplant; 1998 Sep; 22(6):605-7. PubMed ID: 9758354
[TBL] [Abstract][Full Text] [Related]
9. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
10. Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
Woo HY; Min CK; Lee SM; Cho HS; Kim SY; Lee S; Lee JW; Min WS; Kim CC; Kim Y
Eur J Haematol; 2006 Feb; 76(2):160-3. PubMed ID: 16405438
[TBL] [Abstract][Full Text] [Related]
11. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
12. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
Paltiel O; Cournoyer D; Rybka W
Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
[TBL] [Abstract][Full Text] [Related]
13. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
14. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
[TBL] [Abstract][Full Text] [Related]
15. Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation.
Volin L; Ruutu T
Acta Haematol; 1990; 84(4):195-7. PubMed ID: 2125785
[TBL] [Abstract][Full Text] [Related]
16. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
[No Abstract] [Full Text] [Related]
17. Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells.
Fang B; Song Y; Zhao RC; Han Q; Cao Y
Am J Hematol; 2007 Aug; 82(8):772-3. PubMed ID: 17573692
[No Abstract] [Full Text] [Related]
18. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin.
Heyll A; Aul C; Runde V; Arning M; Schneider W; Wernet P
Blood; 1991 Feb; 77(4):906. PubMed ID: 1899624
[No Abstract] [Full Text] [Related]
19. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Yamaguchi M; Sakai K; Murata R; Ueda M
Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
[TBL] [Abstract][Full Text] [Related]
20. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
